CG
LJPC

Cutler Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Cutler Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,600
Closed -$9K – 5416
2018
Q1 		$9K Sell
3,600
-5,800
-62% -$187K ﹤0.01% 2925
2017
Q4 		$26K Buy
9,400
+5,300
+129% +$173K ﹤0.01% 2361
2017
Q3 		$14K Sell
4,100
-38,900
-90% -$1.25M ﹤0.01% 3527
2017
Q2 		$163K Buy
43,000
+2,500
+6% +$71.6K 0.01% 1454
2017
Q1 		$135K Buy
40,500
+16,500
+69% +$421K 0.01% 1487
2016
Q4 		$48K Buy
24,000
+8,100
+51% +$155K ﹤0.01% 2597
2016
Q3 		$32K Buy
15,900
+9,500
+148% +$179K ﹤0.01% 2952
2016
Q2 		$12K Buy
6,400
+3,700
+137% +$66.4K ﹤0.01% 3993
2016
Q1 		$10K Buy
+2,700
New +$48.2K ﹤0.01% 4113

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cutler Group's LJPC Position: Q2 2020 in Review

Cutler Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 100 shares.

Cutler Group first reported a position in LJPC in Q4 2015 and held it in 13 quarters. The position peaked at $506K in Q4 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Cutler Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 100 La Jolla Pharmaceutical Company shares in Q2 2020.
  • Cutler Group first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 13 quarters.
  • Cutler Group's La Jolla Pharmaceutical Company position peaked at $506K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.